News
Benefits and challenges of electronic package leaflet (ePL) - review of ePL pilots in hospital settings in Europe
The article has originally been published in European Journal of Pharmaceutical Sciences issue in October 2023.
The pharmaceutical industry is a critical part of Europe's strategic autonomy
EU legislation must be taken in a direction that is industry- and innovation-friendly. Finland has an important role.
The Government Programme must move to rapid implementation
Prime Minister Petteri Orpo's Government Programme contains many important recordings from the perspective of the pharmaceutical sector. As summer begins to turn to autumn, it's time to roll up the sleeves and start implementing them quickly.
The reform of the EU pharmaceutical legislation threatens to weaken patients' access to new medical treatments
Finland must actively influence the legislative reform and ensure sufficient incentives for pharmaceutical research in Europe.
Joint Statement from the Nordic Pharmaceutical Industry on the implementation of EU HTA Regulation
The upcoming meeting in Stockholm From Theory to Practice: Implementing the EU Health Technology Assessment Regulation is an important event in the Nordics leading up to the implementation in 2025.